<unk>  (known by the trade names Urief in Japan, Rapaflo in North America, and Silodyx or Niksol in the European Union) is a medication for the symptomatic treatment of benign prostatic hyperplasia (BPH). It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate).
Silodosin
Terazosin
Erythrocrine
Doxazosin
Tamsulosin
Oxymetazoline
Methylergometrine
Tropicamide